In this issue:
Changes in B cell subsets after telitacicept
Does normal serology improve effects of DORIS remission and LLDAS?
QRISK3 and SCORE2 for predicting cardiovascular disease risk
Safety and efficacy of guselkumab
Factors leading to flare during pregnancy
Quality of SLE information on TikTok and Bilibili
Factors that distinguish between disease flare and infection
Belimumab for SLE-related mucocutaneous and vasculitis manifestations
Flare rates after COVID-19 vaccination among adolescents
Please login below to download this issue (PDF)